Background In the UK, it is standard practice to treat esophageal adenocarcinoma with
neoadjuvant chemotherapy (no radiation) and surgery. We examined the prognostic value of …

Objectives: To evaluate the histopathologic response to neoadjuvant therapy in esophageal
adenocarcinoma according to impact on prognosis and to suggest a classification for clinical …

Objective Using a population-based registry, we evaluated the impact of neoadjuvant
radiotherapy and lymphadenectomy on survival of patients undergoing curative-intent …

Objective To determine the association between neoadjuvant chemotherapy and
chemoradiation therapy on completeness of pathologic response and to assess the impact …

Objective: To compare overall survival in patients with esophageal adenocarcinoma who
underwent transhiatal esophagectomy (THE) with limited lymphadenectomy or transthoracic …

Background The prognostic value of lymph node regression (LNR) following neoadjuvant
chemotherapy (nCT) for oesophageal and gastro-oeosphageal adenocarcinoma remains …

Objective Accurate staging is vital for esophageal cancer management. The utility of the
American Joint Committee on Cancer (AJCC) staging system 6th edition for esophageal …

AIM: To assess tumour regression grade (TRG) and lymph node downstaging to help define
patients who benefit from neoadjuvant chemotherapy. METHODS: Two hundred and …

Introduction The objective of this study is to explore the prognostic implications of
lymphadenectomy in esophageal cancer patients after neo-adjuvant therapy. Methods …

Background The role of adjuvant therapy in patients with oesophagogastric
adenocarcinoma treated by neoadjuvant chemotherapy is contentious. In UK practice …